Skip to content

Brought to you by

Dentons logo in black and white

Dentons Canada Regulatory Review

The latest information and developments on regulatory law across Canada.

open menu close menu

Dentons Canada Regulatory Review

  • Home
  • About Us
  • Dentons COVID-19 hub

Canadian securities regulators publish conditions of blanket relief for reporting issuers with upcoming periodic filings amid the COVID-19 outbreak

By Andrea Johnson, Leanne Krawchuk, Scott Rozansky, Gary Sollis, Ora Wexler, Bennett Wong, and Andrea Johnson
March 26, 2020
  • COVID-19
  • Securities
Share on Facebook Share on Twitter Share via email Share on LinkedIn

The Canadian Securities Administrators (CSA), together with provincial regulators, have published the conditions required for reporting issuers to benefit from the blanket relief extension in response to the current COVID-19 outbreak. As we published in an alert on March 20, 2020, the CSA had announced issuers would receive a 45-day extension to the date required for filings due on or before June 1, 2020, but did not provide details of the conditions of this relief. The CSA notice published on March 23, 2020, confirms the 45-day extension and advises reporting issuers to review their principal regulator’s harmonized local orders with respect to the specific conditions required to benefit from the blanket relief.

Market participants relying on this exemption are not required to apply for a management cease trade order (MCTO), provided they comply with the conditions of the blanket relief orders. The following conditions shall apply:

  • All filings must be made within 45 days of the deadline for delivery.
  • All issuers relying on the exemption must advise the appropriate securities regulator that they are relying on the exemption at the time the filing is made.
  • In advance of the filing, issuers must issue and file on SEDAR a disclosure that describes:
    • the specific requirements that they rely on for the exemption;
    • that they have implemented an insider trading policy consistent with the principles in section 9 of National Policy 11-207, Failure-to-File Cease Trade Orders and Revocations on Multiple Jurisdictions;
    • the date that the required filing is expected to be delivered; and
    • any material business developments since their last annual financial statements or interim reports, or confirmation that no material business developments have occurred.
  • Issuers must also file a news release on SEDAR as soon as reasonably practicable and no later than 30 days after the filing was due. Subsequent news releases must be filed within 30 days of the initial news release if the filing has not yet been completed.
    • Such news releases must disclose any material business developments since the date of the last news release required by the relief conditions or provide confirmation that no material business developments have occurred.
  • Issuers who rely on the blanket relief shall not file a preliminary prospectus or final prospectus until all required filings have been completed.
  • If the applicable filing is with respect to an annual request form, such annual request form must be delivered before the record date for the issuer’s next annual meeting of shareholders.
  • If the applicable filing is with respect to annual financial statements or management’s discussion and analysis, such documents must be delivered before or concurrently with the delivery of the management information circular for the issuer’s next annual meeting of shareholders.

For issuers with a final base shelf prospectus that has a lapse date from March 23, 2020, to June 1, 2020, a 45-day extension will be applied to such lapse date.

Certain filings required to be made on or before June 1, 2020, shall be subject to an additional 45-day extension, following the original 45-day extension from the date the filing was due. This additional relief shall apply to changes of auditor, notices of change in year-end, business acquisition reports or notices of change in corporate structure.

The increased extension shall also apply to annual financial statements, a notice of use of proceeds, annual disclosure of use of proceeds and an annual filing of a designated rating organization. For issuers to rely on this extension with respect to these filings, the following conditions shall apply:

  • In advance of the filing deadline, issuers must circulate, and file on SEDAR if applicable, a news release that describes the specific requirements that it relies on for the exemption.
  • In the case of a designated rating organization, a news release shall be issued that describes the specific requirements that the issuer relies on for the exemption, which is not required to be filed on SEDAR and should instead be filed with the applicable principal regulator. Such news releases must include both a discussion of information in the designated rating organization’s last annual filing that has become materially inaccurate, or confirmation that there is no materially inaccurate information.

Issuers with filing deadlines after June 1, 2020, who anticipate delays due to the COVID-19 outbreak, or who expect applicable filings to be delayed beyond the applicable relief period for the same reason, may consider preparing or applying for an MCTO. Issuers with filing deadlines on or prior to June 1, 2020, who expect applicable filings to be delayed beyond the applicable relief period should also consider whether to prepare or apply for an MCTO. Applications for an MCTO, which temporarily restricts management and specific insiders from trading, should ordinarily be filed at least two weeks prior to the required filing due date; however, the CSA has committed to accommodating shorter delays as necessary. An MCTO may be issued by a regulator instead of a failure-to-file cease-trade order.

As per the release, the CSA will continue to monitor the impact of the COVID-19 outbreak and issue further guidance as needed.

If you are an issuer with questions on the CSA blanket relief, preparing an MCTO application or would like more information on other securities law matters, please contact Scott Rozansky, Jessica Ward or any of our other key contacts.

This post was originally published on dentons.com.

Share on Facebook Share on Twitter Share via email Share on LinkedIn
Subscribe and stay updated
Receive our latest blog posts by email.
Stay in Touch
Andrea Johnson

About Andrea Johnson

Andrea’s practice focuses on corporate and securities law, with an emphasis on technology and emerging growth companies. She has extensive experience in the private equity and venture capital area and has acted as lead counsel on many of the largest VC financings in Canada. Andrea also advises TSX-listed companies on IPOs, financings (including PIPEs), mergers and acquisitions, stock-based compensation and corporate governance.

All posts Full bio

Leanne Krawchuk

About Leanne Krawchuk

Leanne is a member of the Firm's Corporate group. She is also the Canada Co-chair and a global Lead for Dentons' Mining group and a member of the Dentons Canada LLP National Board and a member of the Dentons Canada LLP Audit Committee.

All posts Full bio

Scott Rozansky

About Scott Rozansky

Scott Rozansky is a partner in Dentons’ Corporate and Commercial law practices. Based in Montréal, Scott serves as co-lead for the Firm’s Montréal Cannabis group, and leads the office’s Venture Technology and Emerging Growth Companies group.

All posts Full bio

Gary Sollis

About Gary Sollis

Gary represents clients in the areas of corporate and securities law, with a focus on acquisitions, financings and reorganizations. He has acted for a variety of public and private companies in financing transactions, including public offerings, private placements of debt and equity, special warrant financings and public and private limited partnership offerings.

All posts Full bio

Ora Wexler

About Ora Wexler

Ora Wexler is a partner in our Corporate group and acts as Toronto office lead for the Securities group. Ora focuses her practice on a variety of public and private capital market transactions and securities regulatory matters.

All posts Full bio

Bennett Wong

About Bennett Wong

Bennett Wong is a partner in the Corporate, Securities and Corporate Finance, and Mergers and Acquisitions practice groups in Calgary. As a trusted business advisor for clients in a wide variety of sectors, including oil and gas, mining, cannabis, agribusiness, chemical, life sciences, healthcare, e-commerce, technology and real estate, Bennett is highly regarded for his pragmatic and proactive approach to bring value and results for his clients.

All posts Full bio

Andrea Johnson

About Andrea Johnson

Andrea’s practice focuses on corporate and securities law, with an emphasis on technology and emerging growth companies. She has extensive experience in the private equity and venture capital area and has acted as lead counsel on many of the largest VC financings in Canada. Andrea also advises TSX-listed companies on IPOs, financings (including PIPEs), mergers and acquisitions, stock-based compensation and corporate governance.

All posts

RELATED POSTS

  • COVID-19
  • Health
  • Product Regulation
  • Regulatory

Regulated health products in 2021: Post-COVID enforcement trends in Canada

By Monica Song and Yulia Konarski | April 27, 2021
  • COVID-19
  • Securities

Update for Canadian public companies: Impacts of COVID-19 on earnings guidance

By Andrea Johnson and Matthew Fleming | March 17, 2020
  • Environmental
  • ESG
  • Regulatory
  • Securities

Consultation Period for CSA Regulation Respecting Disclosure of Climate-related Matters ending February 16, 2022

By Dina Awad and Jade Lemieux | February 9, 2022

About Dentons

Redefining possibilities. Together, everywhere. For more information visit dentons.com

Grow, Protect, Operate, Finance. Dentons, the law firm of the future is here. Copyright 2023 Dentons. Dentons is a global legal practice providing client services worldwide through its member firms and affiliates. Please see dentons.com for Legal notices.

Categories

Dentons logo in black and white

© 2025 Dentons

  • Legal notices
  • Privacy policy
  • Terms of use
  • Cookies on this site